Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 12, 2016 - Issue 8
Submit an article Journal homepage
2,340
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Subcutaneous versus sublingual immunotherapy

Chen Hsing LinDivision of Allergy & Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA;James A. Haley Veterans’ Hospital, Tampa, FL, USACorrespondence[email protected]
,
Sultan AlandijaniDivision of Allergy & Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA;James A. Haley Veterans’ Hospital, Tampa, FL, USA
&
Richard F. LockeyDivision of Allergy & Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA;James A. Haley Veterans’ Hospital, Tampa, FL, USA
Pages 801-803 | Received 01 Apr 2016, Accepted 27 May 2016, Published online: 16 Jun 2016

References

  • Jongejan L, Van Ree R. Modified allergens and their potential to treat allergic disease. Curr Allergy Asthma Rep. 2014;14(12):478.
  • Calderón M, Cardona V, Demoly P. One hundred years of allergen immunotherapy European academy of allergy and clinical immunology celebration: review of unanswered questions. Allergy. 2012;67(4):462–476.
  • Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy. 2007;62:317–324.
  • Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis?. J Allergy Clin Immunol. 2016;137(2):339–349.e10.
  • Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129(3):717–725.e5.
  • Didier A, Malling H-J, Worm M, et al. Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score. Clin Transl Allergy. 2015;5:12.
  • Radulovic S, Wilson D, Calderon M, et al. Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 2011;66(6):740–752.
  • Nelson HS. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?. J Allergy Clin Immunol Pract. 2014;2(2):144–149.
  • Nelson H, Cartier S, Allen-ramey F, et al. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy. J Allergy Clin Immunol Pract. 2015;3(2):256–266.e3.
  • Amar SM, Harbeck RJ, Sills M, et al. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol. 2009;124(1):150–155.
  • Swamy RS, Reshamwala N, Hunter T, et al. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol. 2012;130(1):215–24.e7.
  • Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol. 2009;123(4):763–769.
  • Tabatabaian F, Casale TB. Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT). Allergy Asthma Proc. 2015;36(2):100–104.
  • Cox L. Sublingual immunotherapy for aeroallergens: status in the United States. Allergy Asthma Proc. 2014;35(1):34–42.
  • Epstein TG, Liss GM, Murphy-Berendts K, et al.. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008–2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract. 2014;2:161–167.
  • Cox LS, Larenas Linnemann D, Nolte H, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117(5):1021–1035.
  • Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 2014;7(1):6.
  • Jutel M, Agache I, Bonini S, et al. International consensus on allergen immunotherapy II: mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016;137(2):358–368.
  • Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol. 2008;121(1):227–232.
  • Cox LS, Hankin C, Lockey R. Allergy immunotherapy adherence and delivery route: location does not matter. J Allergy Clin Immunol Pract. 2014;2(2):156–160.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.